Picture of Hisamitsu Pharmaceutical Co logo

4530 — Hisamitsu Pharmaceutical Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Table: Hisamitsu -Q1 group results

Jul 7 (Reuters)-  
             Hisamitsu Pharmaceutical Co Inc  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   3 months ended      3 months ended       Year to  
                  May 31, 2017        May 31, 2016     Feb 28, 2018  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales               36.08               38.15           147.00     
                   (-5.4 pct)          (-3.8 pct)       (+0.7 pct)   
  Operating            5.09                5.74            24.10     
                   (-11.4 pct)         (+0.1 pct)       (-8.4 pct)   
  Recurring            4.94                5.56            25.60     
                   (-11.2 pct)         (-1.8 pct)       (-9.2 pct)   
  Net                  3.67                4.53            18.50     
                   (-18.9 pct)         (+28.1 pct)      (-9.3 pct)   
  EPS               43.92 yen           53.50 yen       221.12 yen   
  EPS Diluted       43.89 yen           53.48 yen                    
  Ann Div                               81.50 yen        82.00 yen   
  -Q2 div                               40.50 yen        41.00 yen   
  -Q4 div                               41.00 yen        41.00 yen   
   
  NOTE - Hisamitsu Pharmaceutical Co Inc.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Hisamitsu Pharmaceutical Co

See all news